Jump to Navigation
contact
legal
privacy policy
Atrial Fibrillation
EAST Trial
Study Centres France
Clinique Ambroise Paré, Neuilly sur Seine
CHU de Nancy, Hôpitaux de Brabois, Vandoeuvre les Nancy
© by
east
- early treatment of atrial fibrillation for stroke prevention trial
Rationale
Design
Summary
Study Centres
Belgium
Czech Republic
Denmark
France
Germany
Great Britain
Italy
Netherlands
Poland
Spain
Switzerland
Partners
Scientific Committees
References
Information for Investigators
Left Sidebar
EAST-AFNET 4 an AFNET/EHRA Trial
News
22.11.2021
|
EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control
Mon, 15.11.2021 Press release
27.08.2021
|
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation
Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation Asymptomatic patients with atrial fibrillation (AF) benefit from early rhythm control therapy comparably to...
25.08.2021
|
EAST-AFNET 4 @ ESC Congress 2021
The latest results of the EAST - AFNET 4 study will be presented at this year's ESC congress:
